Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Israeli firm raises $30.9M, gets CE mark for Parkinson's device
InSightec has raised $30.9 million in a Series C funding round led by GE Healthcare. The Israeli company, which specializes in ultrasound devices, also obtained CE mark approval in Europe for its ExAblate Neuro device designed to treat patients with drug-resistant Parkinson's disease.
MassDevice (Boston) (12/10)
Or we can send an email on your behalf